PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsSeventy-two new gene targets for breast cancer found

BioNews

Seventy-two new gene targets for breast cancer found

Published 8 November 2017 posted in News and appears in BioNews 924

Author

Annabel Slater

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.

Two studies have discovered 72 new genetic variants associated with the risk of developing breast cancer...

Two studies have discovered 72 new genetic variants associated with the risk of developing breast cancer.

One study focused on the 30 percent of resistant breast cancer which do not respond to conventional hormone treatment, and identified ten new variants.

'These findings add significantly to our understanding of the inherited basis of breast cancer,' said Dr Doug Easton of the University of Cambridge, one of the lead investigators. 'As well as identifying new genetic variants, we have also confirmed many that we had previously suspected. There are some clear patterns in the genetic variants that should help us understand why some women are predisposed to breast cancer, and which genes and mechanisms are involved.'

The research was carried out by the OncoArray consortium, which includes more than 550 researchers at 300 research facilities worldwide.

First-degree relatives of breast cancer patients show twice the risk of breast cancer, compared to women without a family history of the disease. However, while there are 180 known genetic variants which increase risk, most of the genetic basis is unknown.

The scientists performed two GWAS studies of over 275,000 breast cancer and control patients of European or East Asian ancestry, using a chip called the OncoArray, and combined their findings with data from past studies. The OncoArray chip identifies single nucleotide polymorphisms (SNPs) across the genome, but particularly in regions thought to be related to cancer.

In one study, published in Nature, the scientists identified 65 new variants which can explain four percent of the heritable risk of breast cancer.

In the second study, published in Nature Genetics, the scientists focused on hormone-resistant breast cancer. They identified ten new variants which were linked to 1.5 percent of heritable risk, including three variants also identified in the Nature study.

Although a few mutations, such as those found in the BRCA1 or BRCA2 genes, can greatly increase the risk of breast cancer, the variants identified in the studies are common and some are carried by over 50 percent of women. Each variant confers only a small amount of risk, but combine to increase overall risk. Most did not code for proteins, but were in regions involved in regulation of genetic expression.

The team say their findings could provide new avenues of research for the genetic basis of breast cancer, particularly for hormone therapy-resistant disease. In combination with other factors influencing risk, their data could also help identify women at a high risk of breast cancer, who may benefit from tailored treatment.

'These women may benefit from more intensive screening, starting at a younger age, or using more sensitive screening techniques, allowing early detection and prevention of the disease,' said team member Professor Jacques Simard of Laval University in Quebec, Canada.

Related Articles

PET BioNews
News
4 May 2018 • 2 minutes read

DNA test may benefit women with hard-to-treat breast cancer

by Dr Jamie Heather

Genetic testing could reveal a subset of patients with aggressive breast cancer who would benefit from a non-standard treatment, a clinical trial has found...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
16 March 2018 • 2 minutes read

'Treasure trove' of genes linked to breast cancer found

by Dr Loredana Guglielmi

A new study has identified 110 genes associated with an increased risk of breast cancer...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
30 January 2018 • 2 minutes read

Screening all women over 30 for BRCA could prevent 64,000 cancers

by Dr Molly Godfrey

The blanket screening of all women over 30 for genetic mutations which cause breast and, or ovarian cancer could prevent more cancers and be more cost effective than current approaches, according to a new study...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
30 January 2018 • 3 minutes read

BRCA gene does not affect survival in those treated for breast cancer

by Dr Hannah Somers

A new study has found that BRCA gene mutations do not affect the survival rates of breast cancer patients under 40...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
20 November 2017 • 2 minutes read

BRCA screening could prevent 1000 cases of breast cancer a year

by Dr Loredana Guglielmi

Researchers have introduced new criteria to screen for BRCA gene mutations that could prevent more than 10,000 cases of cancer and save more than 2000 lives in the next decade...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
24 October 2017 • 3 minutes read

Gene test could improve prediction of breast cancer risk

by Dr Hannah Somers

A new genetic test to accurately predict an individual's risk of developing breast cancer will soon be rolled out at two hospital clinics in Manchester...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
19 October 2017 • 2 minutes read

Researchers crack how BRCA1 gene raises cancer risk

by Dr Loredana Guglielmi

A major breakthrough in understanding how mutations in the BRCA1 gene raise cancer risk has been made by researchers in the USA...

PET BioNews
News
8 May 2017 • 2 minutes read

New approach to tackle breast cancer

by Dr Jamie Heather

Researchers have discovered a new approach to slow the rate of breast cancer tumour growth in mice...

PET BioNews
News
20 March 2017 • 2 minutes read

Existing drugs could benefit one in five breast cancer patients

by Dr Molly Godfrey

A genetic study of breast cancer patients suggests that existing drugs for treating rare breast and ovarian cancers may help more patients than previously thought...

Leave a Reply Cancel reply

You must be logged in to post a comment.

« RNA editing tools could create new disease therapies

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.

Find out how you can advertise here
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
8 August 2022 • 2 minutes read

Placenta and organ formation observed in mouse embryo models

8 August 2022 • 2 minutes read

Lower hormone doses may improve IVF egg quality

8 August 2022 • 2 minutes read

Boosting muscle cell production of gene therapy proteins

1 August 2022 • 2 minutes read

First UK medical guidelines issued for trans fertility preservation

1 August 2022 • 2 minutes read

Male age has more impact on IVF birth rate than previously thought

15 August 2022 • 2 minutes read

Call to end ban on HIV-positive partner gamete 'donation'

15 August 2022 • 2 minutes read

Melanoma invades new tissues using nerve cell gene

15 August 2022 • 2 minutes read

Exceeding alcohol limits could damage DNA and accelerate ageing

15 August 2022 • 2 minutes read

Blood cell gene mutations affect mitochondria, increasing cardiovascular disease risk

15 August 2022 • 2 minutes read

Jumping gene helps immune system fight viruses

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856